Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease

Related Experiment Video

Updated: Oct 17, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

D K Simon1, R Mayeux, K Marder

  • 1Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA. dsimon1@caregroup.harvard.edu

Neurology
|February 19, 2000
PubMed
Abstract

Insights

Mitochondrial DNA (mtDNA) mutations in complex I or tRNA genes do not significantly increase Parkinson

Area of Science:

  • Neurogenetics
  • Mitochondrial Biology
  • Parkinson's Disease Research

Background:

  • Parkinson's disease (PD) is associated with deficient mitochondrial complex I activity.
  • Mitochondrial DNA (mtDNA) mutations are hypothesized to cause this complex I defect in PD.
  • Specific causative mtDNA mutations in PD remain unidentified.

Purpose of the Study:

  • To identify specific mitochondrial DNA (mtDNA) mutations that may predispose individuals to Parkinson's disease (PD).
  • To investigate the role of complex I and tRNA gene mutations in PD pathogenesis.

Main Methods:

  • Complete sequencing of all mtDNA-encoded complex I and tRNA genes in PD patients and controls.
  • Screening of additional PD patients and controls for selected mtDNA mutations using restriction digests.

Main Results:

  • Identified 15 complex I missense and 9 tRNA mutations in PD patients.
  • Rare PD patients carried complex I mutations affecting highly conserved amino acids.
  • No significant differences in mutation frequencies were observed between PD and control groups.
  • Previously reported PD-associated mutations and those linked to Leber's hereditary optic neuropathy were not associated with PD in this study.

Conclusions:

  • High-burden mtDNA mutations in complex I or tRNA genes are unlikely to be a major risk factor for PD in the majority of patients.
  • Further research is needed to explore the potential role of rare mtDNA mutations in the pathogenesis of PD in a subset of individuals.

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...